-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Ngm Biopharmaceuticals Inc quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2020 to Q4 2023.
- Ngm Biopharmaceuticals Inc Earnings Per Share, Basic for the quarter ending December 31, 2023 was -0.34 USD/shares, a 20.9% increase year-over-year.
- Ngm Biopharmaceuticals Inc Earnings Per Share, Basic for the twelve months ending December 31, 2023 was -1.73 USD/shares, a 14.8% increase year-over-year.
- Ngm Biopharmaceuticals Inc annual Earnings Per Share, Basic for 2023 was -1.73 USD/shares, a 14.8% increase from 2022.
- Ngm Biopharmaceuticals Inc annual Earnings Per Share, Basic for 2022 was -2.03 USD/shares, a 30.1% decline from 2021.
- Ngm Biopharmaceuticals Inc annual Earnings Per Share, Basic for 2021 was -1.56 USD/shares, a 4% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)